PTC ASIA 2013/ CeMAT ASIA 2013: Venue and Traffic

SNIEC is jointly owned by German Exposition Corp., a joint subsidiary of Deutsche Messe AG, Messe Duesseldorf GmbH and Messe Muenchen GmbH, and Shanghai Lujiazui Exhibition Development Co.,Ltd.

CeMAT ASIA 2013: Product Category

CEMAT ASIA 2013: Hall planning

CeMAT ASIA 2013: The Future of Logistics Management

The production environment has been changing throughout history. We have seen logistics management and the entire supply chain management ladder change from one of manual operations to one that relies on automation to perform the functions necessary.

CeMAT ASIA: Global Logistics challenges into emerging markets

In developing countries, where shifting politics, unstable economies, lack of basic infrastructure, and limited application of enterprise management technologies are the norm, companies face a crucial decision.

Regulation of food supplement gains momentum in L. America

Experts convened in Bogota to discuss aspects of product, safety, manufacturing, and market

An innovative magazine sampler for Marc Jacobs Daisy

Coty Prestige has announced a unique partnership with Hearst on a first-to-market sampling opportunity, delivering real fragrance directly to readers/consumers.

Behind the mask

Cosmetic facial masks are taking China by storm.Why are cosmetic facial masks so popular now and what are the leading brands?

Gillette gets the highest rank in the industry

The results are in on the 2013 Best Global Brands ranking and Gillette was highest ranked brand in the household and personal products industry at No. 16.

Coperion K-Tron Pitman has a new address but retains location

The company has one official address in Sewell, New Jersey

Medical Innovation: When do the costs outweigh the benefits?

Do fewer complications and faster recovery times result in meaningful financial savings for the health care system as a whole? Or does the cost of high-tech medical innovations outstrip any benefits they might provide?

China’s bitter medicine for foreign drug companies

The objective of Beijing’s action against foreign drug makers appears to be the same: to reduce the prices of drugs and other daily necessities for China’s 1.3 billion people